Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,587.50
Bid: 1,587.00
Ask: 1,587.50
Change: -21.00 (-1.31%)
Spread: 0.50 (0.032%)
Open: 1,604.50
High: 1,609.00
Low: 1,586.50
Prev. Close: 1,608.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks finish higher after very quiet Monday

Mon, 12th Feb 2024 17:11

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

The FTSE 100 index edged up by 0.02% to reach 7,573.69 points, while the FTSE 250 saw a more notable rise of 0.74% to settle at 19,203.93 points.

In currency markets, sterling was last up 0.05% on the dollar to trade at $1.2634, while it rose 0.09% against the euro to change hands at €1.1721.

"The new week has begun with gains for stocks, though once again the FTSE 100 has been left out thanks to weakness in its heavyweight pharmaceutical stocks," said IG chief market analyst Chris Beauchamp.

"European indices have led the way today, and despite fears of broad-based weakness in the eurozone economy both the DAX and CAC 40 continue to hover near record highs."

Beauchamp added that Tuesday's consumer price index reading in the US was looking to be the main event of the week.

"Price growth is expected to keep slowing towards the Fed's target, so investors will be hoping for a bigger-than-expected drop in order to provide the foundations of a rally to fresh record highs for US indices."

UKCP jumps on offer from Tritax, GSK slips

On London's equity markets, UK Commercial Property REIT jumped 4.83% following news of a potential acquisition by Tritax Big Box in a deal valued at £924m.

Tritax, which itself closed down 4%, said it had offered 0.444 new Tritax shares for every UKCP share, leaving it with 76.7% of the merged group and UKCM shareholders with the remainder.

It represented a 10.8% premium to UKCP's closing share price of 64.2 pence per share on 9 February.

Elsewhere, Mike Ashley's retail conglomerate Frasers Group rose 4.98% after announcing an £80m share buyback initiative.

SSP Group saw a modest gain of 1.07% following its acquisition of Airport Retail Enterprises in Australia.

Anglo American climbed 2.88% after signing a memorandum of understanding with Finnish Minerals Group to support Finland's battery strategy.

Finnish Minerals Group is a holding and development company that manages the Finnish Government's mining industry shareholdings and supports the development of the Finnish battery value chain.

Jupiter Fund Management leapt 7% after receiving an upgraded rating to 'neutral' from BNP Paribas Exane.

On the downside, GSK dipped 2.02% despite confirming the US FDA had granted fast track designation for its investigational drug, bepirovirsen, aimed at treating chronic hepatitis B.

Ashmore Group faced a 3.22% drop after JPMorgan maintained its 'underweight' rating on the stock and adjusted the price target downwards, citing concerns about the extent of the recent re-rating.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,573.69 0.02%

FTSE 250 (MCX) 19,203.93 0.74%

techMARK (TASX) 4,388.36 -0.32%

FTSE 100 - Risers

Burberry Group (BRBY) 1,335.50p 5.07%

Frasers Group (FRAS) 822.50p 4.98%

Ocado Group (OCDO) 536.80p 4.60%

Fresnillo (FRES) 493.40p 3.50%

Anglo American (AAL) 1,751.60p 2.88%

Endeavour Mining (EDV) 1,323.00p 2.88%

Glencore (GLEN) 394.25p 2.39%

Antofagasta (ANTO) 1,679.00p 2.25%

Beazley (BEZ) 578.50p 2.21%

Land Securities Group (LAND) 641.80p 2.13%

FTSE 100 - Fallers

Rolls-Royce Holdings (RR.) 309.10p -2.83%

AstraZeneca (AZN) 9,501.00p -2.66%

GSK (GSK) 1,626.40p -2.02%

Melrose Industries (MRO) 594.00p -1.49%

NATWEST GROUP (NWG) 207.70p -1.42%

Sage Group (SGE) 1,175.00p -1.34%

Compass Group (CPG) 2,200.00p -1.21%

Intertek Group (ITRK) 4,416.00p -1.14%

DCC (CDI) (DCC) 5,716.00p -0.90%

Croda International (CRDA) 4,927.00p -0.87%

FTSE 250 - Risers

Jupiter Fund Management (JUP) 86.00p 8.31%

TUI AG Reg Shs (DI) (TUI) 579.50p 5.65%

UK Commercial Property Reit Limited (UKCM) 67.30p 4.83%

Watches of Switzerland Group (WOSG) 410.00p 4.11%

Future (FUTR) 735.00p 3.90%

Direct Line Insurance Group (DLG) 167.50p 3.59%

Dr. Martens (DOCS) 87.85p 3.54%

W.A.G Payment Solutions (WPS) 88.00p 3.53%

Moneysupermarket.com Group (MONY) 252.60p 3.36%

Crest Nicholson Holdings (CRST) 226.00p 3.29%

FTSE 250 - Fallers

Tritax Big Box Reit (BBOX) 153.80p -4.00%

Ashmore Group (ASHM) 222.20p -3.22%

Baltic Classifieds Group (BCG) 228.00p -2.56%

Hilton Food Group (HFG) 791.00p -1.62%

TBC Bank Group (TBCG) 2,895.00p -1.53%

Octopus Renewables Infrastructure Trust (ORIT) 77.80p -1.52%

The Renewables Infrastructure Group Limited (TRIG) 99.80p -1.38%

Trustpilot Group (TRST) 185.70p -1.38%

Inchcape (INCH) 665.50p -1.33%

Diversified Energy Company (DEC) 907.50p -1.31%

More News
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.